Pneumonia, Pulmonary Edema
Conditions
Brief summary
This study aim will be to assess the effectiveness of chest ultrasound as a diagnostic and differentiating modality in cases of pneumonia and lung congestion . It also evaluates chests sonography effectiveness in follow-up of patients with pneumonia and lung congestion .
Detailed description
Lung ultrasound (LUS) is used at the bedside in emergency and critical care settings. It is a rapid and low-cost approach that can direct patient care without the use of harmful radiation. The success of this technique depends on its simplicity to discover the sonographic signs which indicate certain lung pathology. These signs include a hyperechoic and sliding line, moving forward and back with ventilation seen 0.5 cm below the rib line and is called the pleural line. The A-profile associates anterior lung sliding with A lines. A lines are horizontal repetition artifacts of the pleural line. The B-profile associates anterior lung sliding with B lines. B lines appear as shining vertical lines arising from the pleural line and reach the edge of the screen. Several pathological etiologies can fill the alveolar spaces, with fluid (heart failure), pus (pneumonia which is the commonest), blood (pulmonary hemorrhage), and cells (lung cancer). Other causes of lung consolidation may include atelectasis, pulmonary edema, infarction, and lung cancer. Chest imaging with CT is regarded as the gold standard modality allowing for the diagnosis of pneumonia in earlier stage and with higher sensitivity and specificity. On the contrary, cardiogenic pulmonary edema (CPE) is defined as alveolar transudation caused by elevated pulmonary capillary hydrostatic pressure secondary to increased pulmonary venous pressure with low-protein content in the interstitial tissue of lung as a result of cardiac dysfunction
Interventions
DEVICEChest ultrasound
chest ultrasound as a non invasive, low cost & bedside device for differentiation & follow up of lung congestion & pneumonia
Sponsors
Assiut University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult (above 18 years old) * Both genders * Patient with symptoms suggestive of pneumonia * Patient with symptoms suggestive of acute congestive heart failure * admitted to Critical care unit
Exclusion criteria
* Patients with Renal induced lung congestion
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diagnostic tool | Baseline | Diagnosis of pneumonia vs lung congestion by using chest ultrasound examination viewing A-lines, B-lines, pleural effusion presence & its initial amount . |
| Follow up after initiation of treatment | Baseline ( day 3 of hospital admission) | Follow up of findings of chest U.S on day 1 after initiating therapy using same parameters ( A-lines, B-lines, pleural effusion) on day 3 of hospital admission |
| Follow up before assessing final outcome | Baseline ( day 7 of hospital admission) | Follow up of findings of chest U.S on day 1 after initiating therapy using same parameters ( A-lines, B-lines, pleural effusion) on day 7 of hospital admission |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| morbidity & mortality | baseline | if patient's symptoms improved or not If patient died or not |
Countries
Egypt
Contacts
Primary ContactNardin Aymn, resident
Backup ContactAlaa Ahmed, lecturer
Outcome results
None listed